Albilad Capital, GIB Capital, AlRajhi Capital and Alinma Investment have been appointed as Co-underwriters. Lazard Saudi ...

Achieved near-term debt repayment target of $4.5 billion in the fourth quarter of 2024Announced proceeds from $1.2 billion of divestitures signed ...

Mr. Hébert will bring extensive expertise in regulatory affairs, law, government relations, and strategic business management to the Company’s Board of Directors ...

In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing ...

A court ruling means that millions of small businesses need to be prepared to file beneficial ownership information reports.